biomedcentral.com/bmcpharmacoltoxicol/article
Bottom,Top,Right1
  • Welcome Stanford University
  • Log on
  •   BioMed Central
  • Journals
  • Gateways
BMC Pharmacology and Toxicology
unofficial impact factor 3.15
Search for
Advanced search
  • Home
  • Articles
  • Authors
  • Reviewers
  • About this journal
  • My BMC Pharmacology and Toxicology

Submit a manuscript Register Sign up for article alerts Contact us Follow us on Twitter

Explore journal

  •  Editorial Board
  •  Instructions for authors
  •  FAQ
Advertisement

Articles

  • All articles RSS
  • Sections
  • Most viewed RSS
      • Last 30 days
      • Last year
      • All time
  • Archive
  • Supplements

Page 1 of 4

1 2 3 4  Next

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

1.

745
Accesses

Review   Open Access Highly Accessed

A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study

Suzanne Dunne, Bill Shannon, Colum Dunne, Walter Cullen BMC Pharmacology and Toxicology 2013, 14:1 (5 January 2013)

Abstract | Full text | PDF | PubMed

2.

714
Accesses

Research article   Open Access

Clinical outcomes and kinetics of propanil following acute self-poisoning: a prospective case series

Darren M Roberts, Renate Heilmair, Nick A Buckley, Andrew H Dawson, Mohamed Fahim, Michael Eddleston, Peter Eyer BMC Clinical Pharmacology 2009, 9:3 (16 February 2009)

Abstract | Full text | PDF | PubMed

3.

695
Accesses

Research article   Open Access Highly Accessed

Quantitative relationship between the octanol/water partition coefficient and the diffusion limitation of the exchange between adipose and blood

David G Levitt BMC Clinical Pharmacology 2010, 10:1 (7 January 2010)

Abstract | Full text | PDF | PubMed |  Editor’s summary

The limited diffusion of highly fat soluble persistent organic chemicals between adipose tissue and blood can be explained because as the blood/water partition coefficient increases the adipose perfusion rate decreases.

4.

578
Accesses

Case report   Open Access Highly Accessed

Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: A case report

Imran Mohammed, Asif Hussain BMC Clinical Pharmacology 2004, 4:6 (9 August 2004)

Abstract | Full text | PDF | PubMed

5.

522
Accesses

Research article   Open Access

Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers

Isis B Yera-Alos, Liuba Alonso-Carbonell, Carmen M Valenzuela-Silva, Angela D Tuero-Iglesias, Martha Moreira-Martínez, Ivonne Marrero-Rodríguez, Ernesto López-Mola, Pedro A López-Saura BMC Pharmacology and Toxicology 2013, 14:44 (3 September 2013)

Abstract | Full text | PDF | ePUB | PubMed

6.

520
Accesses

Editorial   Open Access

An interview with David H Farb, Section Editor for Basic Pharmacology

David H Farb BMC Pharmacology and Toxicology 2013, 14:42 (30 August 2013)

Abstract | Full text | PDF | ePUB | PubMed |  Editor’s summary

Section Editor David Farb provides his insights on recent developments in the field of pharmacology and discusses his future aspirations for BMC Pharmacology and Toxicology.

7.

520
Accesses

Research article   Open Access Highly Accessed

Finasteride induced depression: a prospective study

Babak Rahimi-Ardabili, Ramin Pourandarjani, Peiman Habibollahi, Amir Mualeki BMC Clinical Pharmacology 2006, 6:7 (7 October 2006)

Abstract | Full text | PDF | PubMed | 1 comment

8.

482
Accesses

Research article   Open Access Highly Accessed

Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people

MRC/BHF Heart Protection Study Collaborative Group BMC Clinical Pharmacology 2009, 9:6 (31 March 2009)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Simvastatin treatment for patients at high risk of cardiovascular events or with diabetes results in only a minor increase in the risk of myopathy and hepatobiliary diseases over 5 years of use.

9.

472
Accesses

Research article   Open Access

Assessing the translatability of In vivo cardiotoxicity mechanisms to In vitro models using causal reasoning

Ahmed E Enayetallah, Dinesh Puppala, Daniel Ziemek, James E Fischer, Sheila Kantesaria, Mathew T Pletcher BMC Pharmacology and Toxicology 2013, 14:46 (6 September 2013)

Abstract | Full text | PDF | ePUB | PubMed

10.

435
Accesses

Research article   Open Access Highly Accessed

Application of microbiological assay to determine pharmaceutical equivalence of generic intravenous antibiotics

Andres F Zuluaga, Maria Agudelo, Carlos A Rodriguez, Omar Vesga BMC Clinical Pharmacology 2009, 9:1 (16 January 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Pharmaceutical equivalence of generic intravenous antibiotics can be assessed prior to their clinical use by providing information about potency and efficacy using a new microbiological assay with reference bacteria

11.

434
Accesses

Debate   Open Access Highly Accessed

Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)

Simon K Mencher, Long G Wang BMC Clinical Pharmacology 2005, 5:3 (26 April 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Truly selective drugs may be less desirable than more 'promiscuous' drugs which correct the imbalance of several molecules involved in a disease process; this viewpoint has implications for current research trends focused on drug selectivity.

12.

414
Accesses

Case report   Open Access

Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature

Maria AP Martins, Adriano MM Reis, Mariana F Sales, Vandack Nobre, Daniel D Ribeiro, Manoel OC Rocha, Antônio LP Ribeiro BMC Pharmacology and Toxicology 2013, 14:27 (4 May 2013)

Abstract | Full text | PDF | ePUB | PubMed

13.

421
Accesses

Research article   Open Access Highly Accessed

Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects

Howard A Smithline, Michael Donnino, David J Greenblatt BMC Clinical Pharmacology 2012, 12:4 (4 February 2012)

Abstract | Full text | PDF | PubMed

14.

412
Accesses

Research article   Open Access Highly Accessed

Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria

Kazeem A Oshikoya, Jacob O Awobusuyi BMC Clinical Pharmacology 2009, 9:14 (11 August 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

Knowledge of adverse drug reactions and the Yellow Card reporting scheme is inadequate among doctors at a teaching hospital in Lagos, Nigeria, and education and training were recognised as the best ways of improving reporting.

15.

409
Accesses

Research article   Open Access Highly Accessed

Bioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteers

Peter M Dewland, Sandie Reader, Phillip Berry BMC Clinical Pharmacology 2009, 9:19 (4 December 2009)

Abstract | Full text | PDF | PubMed |  Editor’s summary

The time to maximum blood concentration of ibuprofen is cut from 90 minutes to just 35 minutes if ibuprofen sodium dihydrate is taken rather than the standard formulation, but adding poloxamer makes no significant difference to bioavailability.

16.

397
Accesses

Case report   Open Access

Tissue concentration of paraquat on day 32 after intoxication and failed bridge to transplantation by extracorporeal membrane oxygenation therapy

Anna Bertram, Sascha Sebastian Haenel, Johannes Hadem, Marius M Hoeper, Jens Gottlieb, Gregor Warnecke, Stanislav Kaschinski, Carsten Hafer, W Nikolaus Kühn-Velten, Detlef Günther, Jan T Kielstein BMC Pharmacology and Toxicology 2013, 14:45 (6 September 2013)

Abstract | Full text | PDF | ePUB | PubMed

17.

358
Accesses

Research article   Open Access Highly Accessed

Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical results

James B Adams, Matthew Baral, Elizabeth Geis, Jessica Mitchell, Julie Ingram, Andrea Hensley, Irene Zappia, Sanford Newmark, Eva Gehn, Robert A Rubin, Ken Mitchell, Jeff Bradstreet, Jane El-Dahr BMC Clinical Pharmacology 2009, 9:16 (23 October 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

18.

351
Accesses

Research article   Open Access Highly Accessed

Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats

Nagesh Gowda, Anilkumar Dandu, Jaideep Singh, Sanghamitra Biswas, Vijaya Raghav, Mudigere N Lakshmi, Pavagada C Shilpa, Venkategowda Sunil, Ashokkumar Reddy, Manojkumar Sadasivuni, Kumaraswamy Aparna, Mahesh Verma, Yoganand Moolemath, Mammen O Anup, Marikunte V Venkataranganna, Baggavalli P Somesh, Madanahalli R Jagannath BMC Pharmacology and Toxicology 2013, 14:28 (21 May 2013)

Abstract | Full text | PDF | ePUB | PubMed |  Editor’s summary

Rats treated with CNX-011-67 demonstrate improved glucose mediated insulin secretion and insulin gene transcription, enhanced glucose oxidation in the form of increased islet ATP content and overall improvement in beta cell health.

19.

343
Accesses

Research article   Open Access

Polycomblike protein PHF1b: a transcriptional sensor for GABA receptor activity

Shamol Saha, Yinghui Hu, Stella C Martin, Sabita Bandyopadhyay, Shelley J Russek, David H Farb BMC Pharmacology and Toxicology 2013, 14:37 (23 July 2013)

Abstract | Full text | PDF | ePUB | PubMed |  Editor’s summary

Polycomblike protein PHF1b stimulates GABRB1 promoter activity in primary cultured neurons and chronic GABA exposure regulates PHF1 binding to endogenous Gabrb1 indicating its role as a molecular transducer of GABA-mediated neurotransmission.

20.

316
Accesses

Research article   Open Access

Tocopheryl acetate 20% spray for elimination of head louse infestation: a randomised controlled trial comparing with 1% permethrin creme rinse

Ian F Burgess, Nazma A Burgess, Elizabeth R Brunton BMC Pharmacology and Toxicology 2013, 14:43 (3 September 2013)

Abstract | Full text | PDF | PubMed

21.

310
Accesses

Research article   Open Access Highly Accessed

Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population

Menna Alene, Michael D Wiese, Mulugeta T Angamo, Beata V Bajorek, Elias A Yesuf, Nasir Wabe BMC Clinical Pharmacology 2012, 12:10 (18 June 2012)

Abstract | Full text | PDF | PubMed

22.

307
Accesses

Research article   Open Access Highly Accessed

The pharmacokinetic profile of a novel fixed-dose combination tablet of ibuprofen and paracetamol

Trevor Tanner, Sue Aspley, Andrew Munn, Tracy Thomas BMC Clinical Pharmacology 2010, 10:10 (5 July 2010)

Abstract | Full text | PDF | PubMed |  Editor’s summary

Paracetemol is absorbed significantly faster when taken in a combination dose with ibuprofen compared to when taken in isolation, with greater blood plasma concentrations of both being reached earlier, offering potentially enhanced pain relief.

23.

292
Accesses

Research article   Open Access

Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2

Shu Liu, David Hsieh, Yi-Lin Yang, Zhidong Xu, Csaba Peto, David M Jablons, Liang You BMC Pharmacology and Toxicology 2013, 14:36 (11 July 2013)

Abstract | Full text | PDF | ePUB | PubMed |  Editor’s summary

Cell-free, in vitro and molecular docking studies indicate that the phytoestrogen coumestrol is a novel ATP competitive and cell permeable Casein kinase 2 (CK2) inhibitor with a submicromolar IC50.

24.

288
Accesses

Review   Open Access

Role of astrocytes in manganese mediated neurotoxicity

Marta Sidoryk-Wegrzynowicz, Michael Aschner BMC Pharmacology and Toxicology 2013, 14:23 (18 April 2013)

Abstract | Full text | PDF | ePUB | PubMed

25.

288
Accesses

Technical advance   Open Access Highly Accessed

Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA

Armin Buchwald, Karl Winkler, Thomas Epting BMC Clinical Pharmacology 2012, 12:2 (11 January 2012)

Abstract | Full text | PDF | PubMed

Page 1 of 4

1 2 3 4  Next


  • Terms and Conditions
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.